PMCPA Case
| Case number | AUTH/2679/11/13 |
| Complainant | Advertising agency employee |
| Company | Bayer |
| Product | Sativex (delta-9-tetrahydrocannabinol and cannabidiol) |
| Issue | POM advertisements accessible on a non-password-protected US creative media website following an awards submission |
| Applicable Code year | 2012 |
| Clauses considered | 2, 9.1, 22.1 (and Clause 24.2 for scope) |
| PMCPA finding | No breach of Clauses 2, 9.1 or 22.1 |
| Scope point | Code applied because the ads referenced UK cost and were placed (indirectly) by the agency engaged by Bayer, meeting Clause 24.2 conditions |
| Complaint received | 20 November 2013 |
| Case completed | 9 January 2014 |
| Appeal | No appeal |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.